DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has one hundred and sixteen approved drugs.
There are twenty-one tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 0 |
| Tradenames: | 103 |
| Ingredients: | 101 |
| NDAs: | 116 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | ARMODAFINIL | armodafinil | TABLET;ORAL | 200043-002 | Jun 1, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | CIPROFLOXACIN EXTENDED RELEASE | ciprofloxacin; ciprofloxacin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 078183-001 | Mar 22, 2007 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 202179-001 | Apr 10, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | SIMVASTATIN | simvastatin | TABLET;ORAL | 090868-005 | Jun 8, 2010 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 077665-002 | May 17, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | VALACYCLOVIR HYDROCHLORIDE | valacyclovir hydrochloride | TABLET;ORAL | 078518-001 | May 24, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | IRBESARTAN | irbesartan | TABLET;ORAL | 200461-002 | Sep 27, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
